NSG 318 exam 3 STUDY
GUIDE LATEST QUESTIONS
AND VERIFIED CORRECT
ANSWERS GRADED A+
what is a life threatening effect from heparin? SATA
a. hemorrhage
b. heparin-induced thrombocytopenia
c. stroke
d. bleding
e. anemia - CORRECT ANSWER-a. hemorrhage
b. heparin-induced thrombocytopenia
which assessment should be done before a patient begins heparin?
a. Obtain history of abnormal clotting or health problems that affect clotting
b. Monitor INR and platelet counts
c. Observe for s/s of active bleeding. Antidote - aminocaproic acid
d. Monitor for bleeding - mouth, stool, urine and skin - CORRECT ANSWER-a. Obtain history of
abnormal clotting or health problems that affect clotting
all others are interventions
which nursing intervention will the nurse FIRST take BEFORE administering heparin?
,a. Monitor PTT/aPTT
b. Monitor platelet counts
c. Monitor for bleeding
d.Keep antidote available - CORRECT ANSWER-a. Monitor PTT/aPTT
other interventions include those but are not done BEFORE admin
make sure to monitor Vital Signs as well
what is the prototype drug for low Molecular-Weight Heparin?
a. enoxaparin (Lovenox)
b. warfarin
c. clopidrogel
d. alteplase - CORRECT ANSWER-a. enoxaparin (Lovenox)
if a pt is experienced an acute MI, which drug would the nurse anticipate the PCP to administer
for prophylaxis reasons?
a. enoxaparin (Lovenox)
b. warfarin
c. heparin
d. alteplase - CORRECT ANSWER-a. enoxaparin (Lovenox)
used
what is the MOA for low Molecular-Weight Heparin?
a. Inhibits factor Xa by increasing inhibition rate of clotting activated by antithrombin III
b. Depresses hepatic synthesis of vitamin K clotting factors
c. Inhibits platelet aggregation and prevent ADP (adenosine diphosphate) from binding with the
ADP platelet receptors
,d. clot buster - CORRECT ANSWER-a. Inhibits factor Xa by increasing inhibition rate of clotting
activated by antithrombin III
what is the route administration for enoxaprin?
a. oral
b. sublingual
c. subcutaneous
d. intramuscular - CORRECT ANSWER-c. subcutaneous every 12 hours
Do this drug require frequent blood draws?
YES OR NO - CORRECT ANSWER-no
Normally does not increase PT or PTT - no need for frequent blood draws
what is the antidote for enoxaprin?
a. aminocaproic acid
b. protamine sulfate
c. vitamin K
d. heparin - CORRECT ANSWER-b. protamine sulfate
if a patient was given enoxaprin and is showing sign of bleeding, hematoma, and anemia, what
is the next intervention the nurse should do?
a. check vital signs
b. call the provider
c. administer protamine sulfate
d. check their labs - CORRECT ANSWER-c. administer protamine sulfate
what is warfarin (coumadin)
, a. Antiplatelet
b. Anticoagulant
c. diuretic
d. thrombolytics - CORRECT ANSWER-b. Anticoagulant
what is warfarin (coumadin) used for? SATA
a. prevent thrombosis
b. PE
c. MI
d. DVT
e. atrial fibrillation
f. thrombosis - CORRECT ANSWER-a. prevent thrombosis
b. PE
c. MI
d. DVT
e. atrial fibrillation
What is the MOA of Warfarin (Coumadin)?
a. Inhibits thrombin, which prevents conversion of fibrinogen to fibrin
b. Depresses hepatic synthesis of vitamin K clotting factors
c. Inhibits platelet aggregation and prevent ADP (adenosine diphosphate) from binding with the
ADP platelet receptors
d. clot buster - CORRECT ANSWER-b. Depresses hepatic synthesis of vitamin K clotting factors
if a patient has hepatic and renal impairment would the nurse...
a. administer with caution
GUIDE LATEST QUESTIONS
AND VERIFIED CORRECT
ANSWERS GRADED A+
what is a life threatening effect from heparin? SATA
a. hemorrhage
b. heparin-induced thrombocytopenia
c. stroke
d. bleding
e. anemia - CORRECT ANSWER-a. hemorrhage
b. heparin-induced thrombocytopenia
which assessment should be done before a patient begins heparin?
a. Obtain history of abnormal clotting or health problems that affect clotting
b. Monitor INR and platelet counts
c. Observe for s/s of active bleeding. Antidote - aminocaproic acid
d. Monitor for bleeding - mouth, stool, urine and skin - CORRECT ANSWER-a. Obtain history of
abnormal clotting or health problems that affect clotting
all others are interventions
which nursing intervention will the nurse FIRST take BEFORE administering heparin?
,a. Monitor PTT/aPTT
b. Monitor platelet counts
c. Monitor for bleeding
d.Keep antidote available - CORRECT ANSWER-a. Monitor PTT/aPTT
other interventions include those but are not done BEFORE admin
make sure to monitor Vital Signs as well
what is the prototype drug for low Molecular-Weight Heparin?
a. enoxaparin (Lovenox)
b. warfarin
c. clopidrogel
d. alteplase - CORRECT ANSWER-a. enoxaparin (Lovenox)
if a pt is experienced an acute MI, which drug would the nurse anticipate the PCP to administer
for prophylaxis reasons?
a. enoxaparin (Lovenox)
b. warfarin
c. heparin
d. alteplase - CORRECT ANSWER-a. enoxaparin (Lovenox)
used
what is the MOA for low Molecular-Weight Heparin?
a. Inhibits factor Xa by increasing inhibition rate of clotting activated by antithrombin III
b. Depresses hepatic synthesis of vitamin K clotting factors
c. Inhibits platelet aggregation and prevent ADP (adenosine diphosphate) from binding with the
ADP platelet receptors
,d. clot buster - CORRECT ANSWER-a. Inhibits factor Xa by increasing inhibition rate of clotting
activated by antithrombin III
what is the route administration for enoxaprin?
a. oral
b. sublingual
c. subcutaneous
d. intramuscular - CORRECT ANSWER-c. subcutaneous every 12 hours
Do this drug require frequent blood draws?
YES OR NO - CORRECT ANSWER-no
Normally does not increase PT or PTT - no need for frequent blood draws
what is the antidote for enoxaprin?
a. aminocaproic acid
b. protamine sulfate
c. vitamin K
d. heparin - CORRECT ANSWER-b. protamine sulfate
if a patient was given enoxaprin and is showing sign of bleeding, hematoma, and anemia, what
is the next intervention the nurse should do?
a. check vital signs
b. call the provider
c. administer protamine sulfate
d. check their labs - CORRECT ANSWER-c. administer protamine sulfate
what is warfarin (coumadin)
, a. Antiplatelet
b. Anticoagulant
c. diuretic
d. thrombolytics - CORRECT ANSWER-b. Anticoagulant
what is warfarin (coumadin) used for? SATA
a. prevent thrombosis
b. PE
c. MI
d. DVT
e. atrial fibrillation
f. thrombosis - CORRECT ANSWER-a. prevent thrombosis
b. PE
c. MI
d. DVT
e. atrial fibrillation
What is the MOA of Warfarin (Coumadin)?
a. Inhibits thrombin, which prevents conversion of fibrinogen to fibrin
b. Depresses hepatic synthesis of vitamin K clotting factors
c. Inhibits platelet aggregation and prevent ADP (adenosine diphosphate) from binding with the
ADP platelet receptors
d. clot buster - CORRECT ANSWER-b. Depresses hepatic synthesis of vitamin K clotting factors
if a patient has hepatic and renal impairment would the nurse...
a. administer with caution
